AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 72 min read$IMAX

Zlatar Jose Aleksandr sold $25K of IMAX

Zlatar Jose Aleksandr (SVP, Controller & PAO) sold 500 shares of IMAX CORP (IMAX) at $49.90 on 2026-08-06.

Original reporting
SEC EDGAR · Zlatar Jose Aleksandr
Published Aug 7, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$IMAX
Neutral
medium confidence
Mentioned
$IMAX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IMAXNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider behavior but does not include any new operational, financial, legal, or strategic information about IMAX.

02

Market read

Traders may log the insider sale as a minor sentiment input, but it is unlikely to drive price without corroborating fundamental news.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs; the transaction size is modest and does not change company guidance or operations.

Relevance 3/10Novelty 2/10Timing: filed 2026-08-07 after-hours

Background

The article is a SEC Form 4 insider transaction disclosure for IMAX, reported by an officer (SVP, Controller & PAO).

Company-level read

Ticker impact

$IMAXNeutralMedium confidence
Context

IMAX SVP, Controller & PAO Jose Aleksandr Zlatar filed a Form 4 open-market sale of 500 shares at $49.90 on 2026-08-06.

Expected impact

Likely minimal near-term impact; treat as low-signal unless follow-on insider selling accelerates.

Evidence & confidence

Form 4 shows a $24,950 sale by an officer, with holdings after transaction of 583 shares; insider sales are common and the filing provides no new company fundamentals.

Market effects

Sector

No clear sector read-through from a single small insider sale.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the filing states no pre-arranged 10b5-1 plan, some traders may interpret it as less routine and watch for additional insider selling.

Key entities

  • public_company
    IMAX CORP

    Issuer of the Form 4 insider transaction; officer sold 500 shares open-market at $49.90.

  • insider
    Zlatar Jose Aleksandr

    SVP, Controller & PAO who reported the sale on SEC Form 4.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

IMAX insider trading history →

Related articles

SEP 9
$IMAXMed

IMAX at Bank of America 2026 Media,Communications & Entertainment Conference: global surge

IMAX Corporation (IMAX) reported strong global growth at the Bank of America 2026 Media, Communications & Entertainment Conference. CEO Rich Gelfond highlighted record box office performance, international expansion, and new revenue streams. Current-quarter box office is on track to exceed $600 million, with significant contributions from international markets and local-language films. The company operates 1,800 theaters, with 500 in backlog, and aims to expand further. IMAX is also diversifying

investing.com3 min
AUG 25
$IMAXMed

Why IMAX Stock Climbed to a New All-Time High Today

IMAX stock reached a new all-time high on Monday, rising 3.89% to $54.79. The surge was driven by the record-breaking success of The Odyssey, which became the highest-grossing IMAX release. CEO Rich Gelfond expects this to be their best year. Analyst Steve Frankel predicts IMAX will exceed estimates in the second half of 2026, with shares potentially rising to $60. The company's Q2 2026 revenue grew 12% to $103 million, with adjusted earnings up 65% to $0.43 per share.

fool.com2 min
AUG 19
$IMAXMed

“The Odyssey” Demand Drives IMAX Shares Higher

IMAX reported Q2 2026 revenue of $103M (up 12% YoY) and EPS of $0.43 (up 65%), driven by strong demand for 'The Odyssey'. The stock has gained 42% YTD, with institutional inflows contributing to a 103.5% rise over the past year. IMAX shows strong sales and EPS growth rates of 11.7% and 18.7% respectively over three years, with EPS expected to rise 14% this year.

yahoo.com2 min
AUG 10
$IMAXMed

Why IMAX Stock Rallied on Monday

IMAX shares rose about 5% on Monday after the company said Christopher Nolan’s film The Odyssey became the highest-grossing IMAX release of all time. IMAX reported $289 million in ticket sales, plus $37 million in the fourth weekend, and said IMAX theaters account for 26% of total tickets. IMAX added that 70mm locations have grossed over $37 million and presales near $40 million.

fool.com3 min
AUG 3
$IMAXMed

Why IMAX Stock Soared on Monday

IMAX said The Odyssey helped it post its highest-ever monthly box-office results, with July box-office revenue of $257 million, up 47% from the prior record. Ticket sales for The Odyssey totaled $221 million. IMAX also announced an upcoming run for Spider-Man: Brand New Day and shares closed Monday nearly 7% higher.

fool.com4 min